Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
On September 30, 2008 Juventus Therapeutics completed a seed funding round with $300,000 in funding from JumpStart Inc.
On October 23, 2008 Juventus Therapeutics completed a series A funding round with $7.7 million in funding from Triathlon Medical Venture Partners and Early Stage Partners.
On July 16, 2012 Juventus Therapeutics completed their series B funding round with $22.2 million in funding from Triathlon Medical Venture Partners (lead investor), New Science Ventures (lead investor), Takeda Ventures, Reservoir Venture Partners, North Coast Angel Fund, New Science Ventures, Fletcher Spaght, and Early Stage Partners.